TILs are lymphocytes isolated from tumor tissues and mainly include CD3+ T cells, CD4+ T cells, and CD8+ T cells, especially CD8+ T cells, which are the basis for producing an effect of immunotherapy (51). This evidence concerns the gene CD8A and neoplasm.